A brief neurocognitive battery is feasible for use in 3-year-olds during acute lymphoblastic leukemia treatment, according to a study published online Dec. 9 in Pediatric Blood & Cancer.
One such type is Acute Lymphoblastic Leukemia (ALL), which is characterised by the uncontrolled proliferation of immature white blood cells known as lymphoblasts. This condition can disrupt normal ...
Despite their initial efficient response to induction chemotherapy, relapse remains frequent in patients with T-cell acute lymphoblastic leukemia (T-ALL), an aggressive malignancy of immature T ...
Opens in a new tab or window SAN DIEGO -- Children with newly diagnosed B-cell acute lymphoblastic leukemia (B-ALL) lived significantly longer without disease recurrence when they received the ...
Researchers sought to assess the risk of developing ALL in patients with multiple myeloma treated with lenalidomide.
HealthDay on MSN20d
Durable Response High With Obe-Cel in B-Cell Acute Lymphoblastic LeukemiaHealthDay News — For patients with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL), obecabtagene autoleucel (obe-cel), an autologous 41BB-ζ anti-CD19 chimeric antigen receptor (CAR) T ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback